Source | Country | Age (years) | Gender | Population | Type of misuse | Dose | N | n | OR (95% CI) | Adjustment, restriction or matching factors | |
---|---|---|---|---|---|---|---|---|---|---|---|
Cohort studies | |||||||||||
Afari-Asiedu 2020 | Ghana | Adults (< 20 to > 60) | M: 36.0% F: 64% | General population | Any misuse | 0.0 | 283 | 27 | 1.00 | Age, gender, marital status, occupation, place of residence, health insurance, type of drug supplier | |
3.5 | 176 | 19 | 0.90 (0.40, 1.70) | ||||||||
8.0 | 138 | 22 | 0.60 (0.30, 1.10) | ||||||||
13.0 | 164 | 34 | 0.40 (0.20, 0.70) | ||||||||
Ho 2010 | Australia | Adults (≥ 18) ≤ 30 to > 45 | M: 43% F: 57% | Emergency department attendants | Non-adherence | 3.0 | 16 | 4 | 1.00 | Age, gender, marital status, employment status, having a regular general practitioner, number of usual medications, place of birth, use of herbal medicine | |
9.0 | 70 | 16 | 0.79 (0.46, 4.55) | ||||||||
12.0 | 35 | 10 | 0.39 (0.06, 2.78) | ||||||||
15.5 | 71 | 9 | 0.33 (0.08, 1.43) | ||||||||
Cross-sectional studies | |||||||||||
Moktan 2021 | India | Adults (> 18) | M: 61.3% F: 38.7% | Attendants of primary care centers | Use without prescription | 0.0 | 28 | 12 | 1.00 | Age, gender, marital status, income, public and private clinics, frequency of doctors’ consultation, family/friend influence (other family members self-medicating with antibiotics), symptoms (minor illness) | |
6.5 | 206 | 65 | 0.61 (0.28, 1.37) | ||||||||
14.5 | 158 | 59 | 0.79 (0.35, 1.80) | ||||||||
19.0 | 112 | 35 | 0.61 (0.26, 1.42) | ||||||||
Bianco 2020 | Italy | Adults mean ± SD: 47.8 ± 16.7 | M: 41.2% F: 58.8% | Attendants of primary care centers | Use without prescription | 4.0 | – | – | 1.00 | Age, gender, marital status, employment status, nationality, having a kid who had used antibiotics in the last year | |
11.0 | – | – | 1.38 (0.86, 2.21) | ||||||||
16.0 | – | – | 1.34 (0.78, 2.29) | ||||||||
Elmahi 2020 | Sudan | Adults (> 18) | M: 52.8% F: 47.2% | General population | Use without prescription | 6.0 | 35 | 23 | 1.00 | Age | |
14.5 | 211 | 125 | 0.76 (0.36, 1.61) | ||||||||
Hallit 2020 | Lebanon | Adults mean ± SD: bad practice 33.33 ± 8.80 good practice 31.49 ± 6.68 | M: 48.5% F: 51.5% | Children caregivers | Any misuse | 3.0 | 48 | 40 | 1.00 | Age | |
11.0 | 40 | 22 | 0.24 (0.09, 0.65) | ||||||||
14.5 | 116 | 41 | 0.11 (0.05, 0.26) | ||||||||
Mallah 2020 | Lebanon | Adults (> 18) | M: 19.4% F: 76.8% | Children caregivers | Any misuse | 6.0 | 252 | 31 | 1.00 | Age, gender, income, area of residence, access to medical care facilities, frequency of telephone medical consultation | |
14.5 | 1157 | 62 | 0.40 (0.27, 0.64) | ||||||||
Nusair 2020 | Jordan | Unrestricted age group > 60 | M: 36.6% F: 63.4% | General population | Use without prescription | 0.0 | 51 | 18 | 1.00 | – | |
5.5 | 52 | 20 | 1.15 (0.51, 2.55) | ||||||||
11.5 | 273 | 104 | 1.13 (0.60, 2.11) | ||||||||
15.5 | 1505 | 632 | 1.33 (0.74, 2.38) | ||||||||
Rathish 2020 | Sri Lanka | Unrestricted age group Mean ± SD: 36.0 ± 21.0 | M: 47% F: 53% | General population | Use without prescription | 11.0 | 252 | 247 | 1.00 | – | |
13.5 | 132 | 127 | 3.95 (0.74, 21.10) | ||||||||
Shah 2020 | Pakistan | ≥ 15 | M: 33% F: 67% | General population | Use without prescription | 0.0 | 45 | 25 | 1.00 | Age | |
4.5 | 231 | 30 | 0.12 (0.06, 0.24) | ||||||||
10.5 | 198 | 54 | 0.30 (0.15, 0.58) | ||||||||
14.5 | 221 | 71 | 0.38 (0.20, 0.73) | ||||||||
Xu 2020 | China | Parents with children < 13 years old | M: 21.5% F: 78.5% | Children caregivers | Use without prescription | 4.5 | 1344 | – | 1.00 | Age, gender, income, medical background, residential location | |
11.0 | 1771 | – | 0.85 (0.58, 1.25) | ||||||||
14.5 | 3164 | – | 0.77 (0.53, 1.14) | ||||||||
Antibiotic Storage | 4.5 | 1344 | – | 1.00 | |||||||
11.0 | 1771 | – | 1.38 (1.19, 1.60) | ||||||||
14.5 | 3164 | – | 1.55 (1.33, 1.81) | ||||||||
Ateshim 2019 | Eritrea | Median (IQR): 37 (24) | M: 41.2% F: 58.8% | General population | Use without prescription | 0.0 | 32 | 11 | 1.00 | Age, gender, income, marital status, occupational status, knowledge about antibiotics, attitudes towards antibiotics | |
3.0 | 64 | 22 | 1.96 (0.56, 6.88) | ||||||||
6.5 | 95 | 33 | 1.62 (0.46, 5.72) | ||||||||
9.5 | 246 | 111 | 1.92 (0.55, 6.69) | ||||||||
14.0 | 140 | 81 | 2.8 (0.74, 10.63) | ||||||||
Bogale 2019 | Ethiopia | 18 to > 60 | M: 41.3% F: 58.7% | General population | Use without prescription | 0.0 | – | 26 | 6.39 (1.45, 28.19) | Age, gender, income, marital status, residential location, occupational status, healthcare profession | |
4.5 | – | 72 | 1.50 (0.82, 2.74) | ||||||||
10.5 | – | 75 | 1.46 (0.74, 2.87) | ||||||||
14.5 | 81 | 1.00 | |||||||||
Bulabula 2019 | South Africa | Mean ± SD: 29 ± 6.1 | F: 100% | Pregnant women attending public hospital | Use without prescription | 5.0 | 14 | – | 1.00 | Age, gender, income, residential location,, knowledge about antibiotics, attitudes towards antibiotics | |
11.0 | 228 | – | 1.25 (0.15, 10.10) | ||||||||
15.5 | 5 | – | 1.60 (1.03, 2.55) | ||||||||
Ekambi 2019 | Cameroon | ≥ 15 Mean ± SD: 35.02 ± 10.5 | M: 52% F: 48% | Attendants of pharmacies | Use without prescription | 3.0 | 25 | 8 | 1.00 | Age, gender, marital status, occupation | |
10.0 | 86 | 28 | 1.02 (0.94, 2.66) | ||||||||
15.0 | 66 | 33 | 2.07 (1.10, 4.00) | ||||||||
Mate 2019 | Mozambique | Adults (> 18) Median (IQR): 33 (25–47) | M: 26.9% F: 73.1% | General population | Use without prescription | 0.0 | 69 | 17 | 1.00 | Age | |
4.0 | 344 | 63 | 0.69 (0.37, 1.26) | ||||||||
11.5 | 555 | 119 | 0.83 (0.47, 1.50) | ||||||||
14.5 | 114 | 28 | 1.00 (0.50, 1.99) | ||||||||
Non-adherence | 0.0 | 65 | 15 | 1.00 | |||||||
4.0 | 334 | 88 | 1.19 (0.64, 2.23) | ||||||||
11.5 | 531 | 177 | 1.67 (0.91, 3.05) | ||||||||
14.5 | 110 | 33 | 1.43 (0.70, 2.90) | ||||||||
Mukattash 2019 | Jordan | 20 to ≥ 50 | M: 15.8% F: 84.2% | Children caregivers | Use without prescription | 6.0 | 205 | 106 | 1.00 | Age | |
18.0 | 1487 | 554 | 0.56 (0.42, 0.75) | ||||||||
Rajendran 2019 | India | Adults (> 18) | M: 51% F: 49% | General population | Use without prescription | 9.5 | 151 | 2 | 1.00 | Age | |
11.0 | 60 | 2 | 2.57 (0.35, 18.67) | ||||||||
14.0 | 540 | 21 | 3.01 (0.70, 13.00) | ||||||||
Sun 2019 | China | Parents with children < 13 years old | M: 23.5% F: 76.5% | Children caregivers | Antibiotic storage | 5.0 | 2519 | 1026 | 1.00 | Age, gender of the parents, gender of the child, socioeconomic characteristics (residential location and GDP per capita), health insurance, specialty (medical vs non-medical) | |
11.0 | 2765 | 1365 | 1.34 (1.20, 1.51) | ||||||||
14.5 | 4242 | 2189 | 1.50 (1.33, 1.70) | ||||||||
Voidăzan 2019 | Romania | Adults (20–80) Mean ± SD: 45 ± 12.5 | M: 36.5% F: 63.5% | Attendants of primary care centers | Use without prescription | 2.5 | 200 | 11 | 1.00 | – | |
9.0 | 564 | 94 | 3.43 (1.80, 6.56) | ||||||||
15.0 | 438 | 102 | 5.22 (2.73, 9.96) | ||||||||
22.5 | 790 | 77 | 1.86 (0.97, 3.56) | ||||||||
Adisa 2018 | Nigeria | Mothers of children under five | F: 100% | Mothers of children under five attending primary care centers | Use without prescription | 3.0 | 19 | 8 | 1.00 | Gender | |
9.5 | 148 | 89 | 2.07 (0.79, 5.46) | ||||||||
14.5 | 160 | 73 | 1.15 (0.44, 3.02) | ||||||||
Al-Qahtani 2018 | Saudi Arabia | Adults (≥ 18) | M: 43.4% F: 56.6% | Attendants to primary care centers | Use without prescription | 0.0 | 13 | 4 | 1.00 | Age, gender | |
3.5 | 39 | 13 | 1.13 (0.29, 4.35) | ||||||||
10.5 | 108 | 39 | 1.27 (0.37, 4.40) | ||||||||
15.5 | 281 | 119 | 1.65 (0.50, 5.49) | ||||||||
21.0 | 48 | 23 | 2.07 (0.56, 7.65) | ||||||||
Chang 2018 | China | Caregivers of children under seven | M: 33.3% F: 66.7% | Caregivers of children under seven | Use without prescription | 4.5 | 336 | – | 1.00 | Gender, child gender and age, number of children, health insurance, residential location | |
11.0 | 1428 | – | 0.75 (0.57, 0.98) | ||||||||
14.5 | 1407 | – | 0.82 (0.62, 1.08) | ||||||||
19.0 | 187 | – | 0.86 (0.56, 1.32) | ||||||||
Cheng 2018 | China | 30 to ≥ 71 | M: 41.4% F: 68.3% | General rural population | Use without prescription | 0.0 | 135* | 83* | 1.00 | Age, gender, household size, health insurance | |
3.5 | 165* | 112* | 1.19 (0.69, 2.05) | ||||||||
8.0 | 227* | 139* | 0.89 (0.50, 1.57) | ||||||||
13.0 | 97* | 57* | 0.84 (0.40, 1.74) | ||||||||
Dar-Odeh 2018 | Saudi Arabia | 15–64 Mean ± SD: 29.08 ± 9.32 | M: 40.7% F: 59.3% | Attendants of primary care centers | Use without prescription | 6.0 | 138 | 47 | 1.00 | Age | |
15.5 | 333 | 81 | 0.63 (0.41, 0.97) | ||||||||
21.0 | 29 | 7 | 0.62 (0.25, 1.56) | ||||||||
El-Sherbiny 2018 | Egypt | Adults (≥ 18) | M: 50.3% F: 49.7% | Attendants of primary care centers | Any misuse | 6.0 | 419 | – | 1.00 | Age, gender, income, occupation, residential location | |
14.5 | 181 | – | 0.52 (0.34, 0.79) | ||||||||
Horumpende 2018 | Tanzania | Median (IQR): 23 (20.5–36.5) | M: 53.33% F: 46.67% | General population | Use without prescription | 0.0 | 17 | 9 | 1.00 | Age, gender, income, marital status, occupation | |
4.0 | 111 | 70 | 1.45 (0.46, 4.51) | ||||||||
10.0 | 172 | 95 | 1.02 (0.32, 3.25) | ||||||||
Kamata 2018 | Japan | 20–69 | M: 51.2% F: 48.8% | General population | Antibiotic storage | 5.0 | 111 | 18 | 1.00 | Age | |
11.0 | 1265 | 115 | 0.52 (0.30, 0.89) | ||||||||
14.5 | 1932 | 254 | 0.78 (0.46, 1.32) | ||||||||
Non-adherence | 5.0 | 111 | 26 | 1.00 | |||||||
11.0 | 1265 | 282 | 0.94 (0.59, 1.48) | ||||||||
14.5 | 1932 | 479 | 1.08 (0.69, 1.69) | ||||||||
Ngu 2018 | Cameroon | ≥ 21 Median (IQR): 35 (27—49) | M: 44.8% F: 55.2% | Attendants of primary care centers | Use without prescription | 0.0 | 29 | 14 | 1.00 | Age | |
6.5 | 279 | 115 | 0.75 (0.35, 1.62) | ||||||||
Redzick 2018 | Croatia | – | M: 26.1% F: 73.9% | Attendants of primary care centers | Use without prescription | 4.5 | 32 | 8 | 1.00 | Age | |
10.5 | 312 | 38 | 0.42 (0.17, 0.99) | ||||||||
14.5 | 60 | 4 | 0.21 (0.06, 0.78) | ||||||||
19.0 | 140 | 12 | 0.28 (0.10, 0.76) | ||||||||
Tong 2018 | China | < 45 to > 60 | M: 47.6% F: 52.4% | Attendants of primary care centers | Non-adherence | 6.5 | 323 | 286 | 1.00 | Age, gender, income, residential location, occupation, employment status, knowledge about antibiotics | |
14.5 | 391 | 335 | 0.77 (0.50, 1.21) | ||||||||
Abdelrahman 2017 | Saudi Arabia | < 18 to > 65 | M: 71.5% F: 28.5% | General population | Use without prescription | 0.0 | 8 | 4 | 1.00 | Age | |
5.0 | 58 | 21 | 0.57 (0.13, 2.51) | ||||||||
11.0 | 360 | 117 | 0.48 (0.12, 1.96) | ||||||||
15.5 | 602 | 248 | 0.70 (0.17, 2.83) | ||||||||
Albawani 2017 | Yemen | ≥ 18 Mean ± SD: 28.6 ± 7.7 | M: 56.2% F: 43.8% | Attendants of pharmacies | Use without prescription | 5.0 | 40 | 36 | 1.00 | Age | |
11.0 | 71 | 68 | 2.52 (0.53, 11.87) | ||||||||
15.0 | 229 | 191 | 0.56 (0.19, 1.66) | ||||||||
Akici 2017 | Turkey | ≥ 15 | M: 42.6% F: 57.4% | Attendants of primary care centers | Use without prescription | 0.0 | 18 | 8 | 1.00 | – | |
4.5 | 18 | 6 | 0.63 (0.16, 2.41) | ||||||||
10.5 | 18 | 8 | 1.11 (0.29, 4.20) | ||||||||
14.5 | 18 | 9 | 1.25 (0.34, 4.64) | ||||||||
Non-adherence | 0.0 | 9 | 6 | 1.00 | |||||||
4.5 | 9 | 6 | 1.00 (0.14, 7.10) | ||||||||
10.5 | 9 | 7 | 1.75 (0.22, 14.22) | ||||||||
14.5 | 9 | 7 | 1.75 (0.22, 14.22) | ||||||||
Antibiotic storage | 0.0 | 8 | 3 | 1 | |||||||
4.5 | 9 | 4 | 1.67 (0.23, 12.22) | ||||||||
10.5 | 8 | 5 | 2.78 (0.37, 21.03) | ||||||||
14.5 | 9 | 6 | 3.33 (0.45, 24.44) | ||||||||
Barber 2017 | Philippines | Adults (≥ 18) Median (IQR): 32 (20) | M: 37.2% F: 56.7% | General population | Use without prescription | 3.5 | 83 | 69 | 1.00 | Age, gender, household size | |
10.5 | 186 | 143 | 0.77 (0.30, 1.67) | ||||||||
Erku 2017 | Ethiopia | < 29 to > 60 Mean ± SD: 33.19 ± 10.82 | M: 25.9% F: 74.9% | General population | Use without prescription | 0.0 | 182 | 125 | 5.01 (2.62, 9.34) | Age, gender, income, marital status, household size, employment status, frequency of visiting health care institutions, satisfaction about healthcare service | |
4.5 | 201 | 180 | 2.81 (1.32, 6.15) | ||||||||
10.5 | 179 | 159 | 1.96 (0.91, 4.51) | ||||||||
14.5 | 88 | 71 | 1.00 | ||||||||
Gebrekirstos 2017 | Ethiopia | Adults (≥ 18) Median (IQR): 30 (16) | M: 60.6% F: 39.4% | Attendants of pharmacies | Use without prescription | 0.0 | 152 | 75 | 1.00 | Age, gender, income, marital status, employment status, household size, residential location, type of illness, healthcare insurance, previous experience with antibiotics, access to healthcare | |
4.5 | 149 | 71 | 0.93 (0.59, 1.47) | ||||||||
10.5 | 260 | 121 | 0.89 (0.60, 1.33) | ||||||||
14.5 | 219 | 100 | 0.86 (0.60, 1.31) | ||||||||
Hassali 2017 | Malaysia | Adults (≥ 18) Mean ± SD: 28.7 ± 7.4 | M: 42.75% F: 57.25% | General population | Any misuse | 8.5 | 61 | 20 | 1.00 | Age, gender, income, marital status, race, healthcare related occupation, employment status, health insurance | |
14.0 | 339 | 111 | 0.83 (0.53, 1.31) | ||||||||
Jamhour 2017 | Lebanon | Adults (≥ 18) | M: 45.5% F: 54.5% | General population | Use without prescription | 4.5 | 34 | 14 | 1.00 | Age, gender, educational level, specialty (unrelated to health care) | |
11.0 | 151 | 76 | 1.45 (0.68, 3.08) | ||||||||
Kajeguka 2017 | Tanzania | Adults (≥ 18) Mean ± SD: 35.4 ± 13.4 | M: 48.0% F: 52.0% | General population | Use without prescription | 0.0 | 26 | 16 | 1.00 | Age, gender, income, marital status, employment status, self-treated condition | |
4.0 | 87 | 33 | 0.38 (0.12, 0.94) | ||||||||
11.0 | 74 | 46 | 1.03 (0.41, 2.57) | ||||||||
16.0 | 133 | 72 | 1.10 (0.46, 2.64) | ||||||||
Kurniawan 2017 | Indonesia | Adults (≥ 18) Median (IQR): 45 (18–49) | M: 34.3% F: 65.8% | Attendants of primary care centers | Use without prescription | 3.5 | 26 | 24 | 1.00 | Age, gender, income, marital status, employment status, health insurance | |
8.0 | 44 | 37 | 0.44 (0.08, 2.30) | ||||||||
11.0 | 139 | 101 | 0.22 (0.05, 0.98) | ||||||||
14.5 | 31 | 18 | 0.12 (0.02, 0.58) | ||||||||
Senadheera 2017 | Sri Lanka | Adults (≥ 18) | M: 31.30% F: 68.70% | General population | Use without prescription | 11.0 | 362 | 14 | 1.00 | Age, gender, income, employment status, health insurance, household size, receiving medical treatment in the last three months, knowledge of antibiotic name | |
13.5 | 245 | 37 | 0.32 (0.17, 0.63) | ||||||||
Torres 2017 | Ecuador | Adults (≥ 18) range: 18—64 | M: 45.6% F: 54.4% | General population | Use without prescription | 3.5 | 51 | 22 | 1.00 | Age | |
10.5 | 173 | 83 | 1.22 (0.65, 2.28) | ||||||||
14.5 | 195 | 102 | 1.45 (0.78, 2.69) | ||||||||
Abdulraheem 2016 | Nigeria | Adults (≥ 18) Median (range): 25 (19–68) | M: 61.1% F: 38.9% | Attendants of primary care centers | Use without prescription | 3.5 | 623 | – | 1.00 | Age, gender, symptoms, occupation | |
9.5 | 390 | – | 1.24 (1.13, 1.87) | ||||||||
14.5 | 137 | – | 1.32 (1.18, 1.96) | ||||||||
Aleem 2016 | Saudi Arabia | < 25 to ≥ 55 | M: 39.5% F: 60.5% | Children caregivers | Use without prescription | 6.0 | 102 | 29 | 1.00 | Age, gender, income, household size | |
15.0 | 508 | 42 | 0.23 (0.13, 0.39) | ||||||||
Al Rasheed 2016 | Saudi Arabia | Adults (> 18) | M: 23.2% F: 76.8% | Attendants of primary care centers | Use without prescription | 0.0 | 100 | 13 | 1.00 | Age, gender, marital status, employment status, occupation, symptoms | |
3.5 | 186 | 16 | 1.59 (0.73, 3.45) | ||||||||
10.5 | 145 | 13 | 1.52 (0.67, 3.43) | ||||||||
15.5 | 145 | 50 | 0.28 (0.14, 0.59) | ||||||||
Bilal 2016 | Pakistan | Mean ± SD: 48.6 ± 4.4 | M: 65.8% F: 34.2% | Attendants of primary care centers | Use without prescription | 0.0 | 161 | 159 | 1.00 | Age, residential location, specialty (non-medical related participants) | |
9.5 | 86 | 81 | 0.20 (0.04, 1.07) | ||||||||
11.5 | 65 | 49 | 0.04 (0.01, 0.17) | ||||||||
14.5 | 50 | 26 | 0.01 (0.003, 0.06) | ||||||||
19.5 | 38 | 10 | 0.004 (0.001, 0.02) | ||||||||
Nigigi 2016 | Kenya | Adults (≥ 18) | M: 32.0% F: 68.0% | Attendants of primary care centers | Use without prescription | 0.0 | 48 | 12 | 1.00 | – | |
4.0 | 115 | 35 | 1.13 (0.90, 1.97) | ||||||||
9.5 | 179 | 61 | 1.31 (0.92, 2.40) | ||||||||
13.5 | 20 | 9 | 1.57 (1.20, 2.50) | ||||||||
Ding 2015 | China | Adults ≤ 29 to > 50 | M: 9.7% F: 90.3% | Children caregivers | Non-adherence | 3.0 | 198 | 68 | 1.00 | Age, access to healthcare (number of clinics) | |
8.0 | 304 | 87 | 0.77 (0.52, 1.13) | ||||||||
13.0 | 120 | 47 | 1.23 (0.77, 1.97) | ||||||||
Gebeyehu 2015 | Ethiopia | Mean ± SD: urban: 34.1 ± 12.9 rural: 34.5 ± 11.5 | M: 24.3% F: 75.7% | General population | Use without prescription | 0.0 | 137 | 56 | 4.21 (1.47, 12.07) | Age, gender, educational level, marital status, employment status, residential location, household size, level of healthcare service satisfaction, knowledge on antibiotics use | |
4.5 | 145 | 40 | 2.01 (0.93, 4.34) | ||||||||
10.5 | 89 | 14 | 1.01 (0.34, 2.94) | ||||||||
14.5 | 35 | 10 | 1 | ||||||||
Kusturica 2015 | Serbia | Adults (≥ 18) | M: 20.1% F: 79.9% | General population | Antibiotic storage | 4.5 | 27 | 9 | 1.00 | Age | |
10.5 | 169 | 75 | 1.60 (0.68, 3.76) | ||||||||
14.0 | 25 | 10 | 2.53 (0.89, 7.23) | ||||||||
16.5 | 162 | 84 | 2.15 (0.91, 5.08) | ||||||||
Pavyde 2015 | Lithuania | Adults (≥ 18) Mean ± SD: 38.6 ± 13.9 | M: 42.1% F: 57.9% | Attendants of pharmacies | Use without prescription | 6.0 | 298 | – | 1.00 | Age, gender, residential location, parenthood, knowledge of antibiotics, occupation | |
14.5 | 707 | – | 1.39 (0.90, 2.16) | ||||||||
Yousif 2015 | Saudi Arabia | Adults (≥ 18) | M: 57.0% F: 43.0% | General population | Use without prescription | 6.0 | 96 | 80 | 1.00 | Age, gender, income, marital status, employment status, residential location | |
15.5 | 295 | 235 | 1.25 (0.71, 2.50) | ||||||||
Cheaito 2014 | Lebanon | Adults (≥ 18) Mean ± SD: 38.24 ± 13.7 | M: 44.8% F: 55.2% | Attendants of pharmacies | Use without prescription | 3.0 | 67 | 34 | 1.00 | Age, gender, income, marital status, employment status, health insurance, having a reference doctor and frequency of consultation | |
10.5 | 96 | 42 | 0.75 (0.40, 1.41) | ||||||||
17.5 | 156 | 58 | 0.57 (0.32, 1.02) | ||||||||
Vásquez 2014 | Ecuador | ≥ 65 | M: 45.8% F: 54.2% | General population | Use without prescription | 3.0 | 463 | 52 | 1.00 | Age | |
11.5 | 205 | 26 | 1.15 (0.69, 1.90) | ||||||||
Hu 2014 | Australia | ≥ 14 Mean ± SD: 33 ± 8.2 | M: 45.0% F: 55.0% | General population | Use without prescription | 6.0 | 67 | 14 | 1.00 | Age, gender, income, residential location, employment status, marital status, parental status, language proficiency, main language spoken at home, health insurance | |
14.5 | 402 | 134 | 1.89 (1.01, 3.53) | ||||||||
Mihretie 2014 | Ethiopia | ≥ 17 Mean ± SD: 37.8 ± 12.2 | M: 4.4% F: 95.6% | General population | Use without prescription | 4.0 | 29 | 27 | 1.00 | Age | |
10.5 | 7 | 3 | 0.06 (0.01, 0.44) | ||||||||
14.5 | 9 | 4 | 0.06 (0.01, 0.42) | ||||||||
Ramalhinho 2014 | Portugal | Adults (≥ 18) | M: 48.7% F: 51.3% | General population | Use without prescription | 4.5 | 308* | 268* | 0.84 (1.41, 11.78) | Age, gender, marital status, employment status, residential location, access to healthcare, chronic disease, easy access to unprescribed antibiotics, occupation | |
11.0 | 445* | 340* | 1.25 (0.66, 5.45) | ||||||||
15.5 | 293* | 223* | 1.00 | ||||||||
Yu 2014 | China | Adults ≤ 20 to > 40 | M: 25.6% F: 74.4% | Children caregivers | Use without prescription | 3.5 | 16 | – | 0.19 (0.05, 0.75) | Age, gender, child age, number of children, medical insurance | |
8.0 | 371 | – | 1.07 (0.64, 1.81) | ||||||||
11.0 | 258 | – | 1.01 (0.62, 1.65) | ||||||||
14.5 | 203 | – | 1.00 | ||||||||
Abobotain 2013 | Saudi Arabia | < 25 to ≥ 55 | M: 39.5% F: 60.5% | Children caregivers | Use without prescription | 6.0 | 102 | 29 | 1.00 | Age, income, marital status, household size, number of children, healthcare related profession | |
14.5 | 508 | 42 | 0.23 (0.13, 0.39) | ||||||||
Ecker 2013 | Peru | Mean ± SD: 31.4 ± 10.8 | F: > 94.9% | Children caregivers | Use without prescription | 3.5 | 188 | – | 1.00 | Age, gender, caregiver-child relatedness, age of the child, access to healthcare | |
9.0 | 781 | – | 1.2 (0.7, 1.9) | ||||||||
14.5 | 232 | – | 1.0 (0.5, 1.7) | ||||||||
Ekwochi 2013 | Nigeria | – | M: 59.0% F: 41.0% | Children caregivers | Use without prescription | 3.0 | 31 | 19 | 1.00 | – | |
9.5 | 83 | 45 | 0.75 (0.32, 1.74) | ||||||||
14.5 | 96 | 34 | 0.35 (0.15, 0.80) | ||||||||
Ivanovska 2013 | Macedonia | Adults (≥ 18) | M: 31.3% F: 68.7% | General population | Use without prescription | 0.0 | 11 | 4 | 1.00 | Age, occupation | |
5.0 | 41 | 21 | 1.83 (0.47, 7.25) | ||||||||
11.5 | 256 | 112 | 1.36 (0.39, 4.77) | ||||||||
16.0 | 94 | 37 | 1.14 (0.31, 4.15) | ||||||||
Antibiotic storage | 0.0 | 11 | 6 | 1.00 | |||||||
5.0 | 41 | 28 | 1.79 (0.46, 6.97) | ||||||||
11.5 | 256 | 187 | 2.26 (0.67, 7.64) | ||||||||
16.0 | 94 | 66 | 1.96 (0.55, 6.97) | ||||||||
Khalil 2013 | Saudi Arabia | ≥ 15 | M: 80.8% F: 19.1% | Attendants of primary care centers | Use without prescription | 4.5 | 107 | 93 | 1.00 | – | |
11.0 | 435 | 350 | 0.62 (0.34, 1.14) | ||||||||
15.5 | 233 | 180 | 0.51 (0.27, 0.97) | ||||||||
21.0 | 18 | 14 | 0.53 (0.15, 1.83) | ||||||||
Moradi 2013 | Iran | Mean ± SD: 29.2 ± 8.05 | M: 33.3% F: 66.7% | Attendants of pharmacies and primary care centers | Non-adherence | 2.5 | 23 | 16 | 1.00 | – | |
11.0 | 50 | 36 | 1.13 (0.38, 3.32) | ||||||||
15.5 | 19 | 6 | 0.20 (0.05, 0.75) | ||||||||
Chan 2012 | Hong Kong, China | Adults (≥ 18) | M: 46.0% F: 54.0% | General population | Non-adherence | 3.0 | 47 | – | 1.00 | Age, gender, antibiotic knowledge | |
9.5 | 165 | – | 1.77 (0.76, 4.11) | ||||||||
14.5 | 150 | – | 2.18 (0.85, 5.55) | ||||||||
Elberry 2012 | Saudi Arabia | ≥ 20 | F: 100% | Mothers | Use without prescription | 6.0 | 34 | 2 | 1.00 | Gender | |
15.5 | 116 | 11 | 1.68 (0.35, 7.96) | ||||||||
21.0 | 49 | 6 | 2.23 (0.42, 11.79) | ||||||||
Grosso 2012 | Italy | < 25 to > 65 | M: 43.1% F: 56.9% | Attendants of primary care centers | Use without prescription | 4.0 | 489 | 82 | 0.39 (0.26, 0.61) | Age, gender, occupation | |
11.0 | 268 | 61 | 0.41 (0.26, 0.64) | ||||||||
16.0 | 176 | 74 | 1.00 | ||||||||
Non-adherence | 4.0 | 502 | 169 | 1.77 (1.13, 2.75) | |||||||
11.0 | 276 | 45 | 0.79 (0.48, 1.31) | ||||||||
16.0 | 178 | 33 | 1.00 | ||||||||
Clark 2011 | Azerbaijan | Adults (≥ 18) | M: 43.6% F: 56.4% | General population | Use without prescription | 0.0 | 35 | 8 | 1.00 | Age, gender, ethnicity, household size | |
7.0 | 646 | 123 | 1.23 (0.45, 3.36) | ||||||||
10.5 | 74 | 14 | 1.25 (0.37, 4.17) | ||||||||
13.5 | 37 | 9 | 1.48 (0.37, 5.93) | ||||||||
Widayati 2011 | Indonesia | Adults (≥ 18) | M: 38.3% F: 61.7% | General population | Use without prescription | 3.5 | 8 | 5 | 1.00 | Age, gender, income, marital status, household size, employment status, healthcare insurance | |
8.0 | 8 | 3 | 0.36 (0.05, 2.73) | ||||||||
11.0 | 31 | 17 | 0.73 (0.15, 3.60) | ||||||||
14.5 | 21 | 8 | 0.37 (0.07, 1.98) | ||||||||
Barah 2010 | Syria | Adults (≥ 18) | M: 52% F: 48% | General population | Use without prescription | 5.0 | 80 | 54 | 1.00 | Age | |
11.0 | 83 | 66 | 1.87 (0.92, 3.80) | ||||||||
15.5 | 89 | 55 | 0.78 (0.42, 1.47) | ||||||||
21.0 | 90 | 57 | 0.83 (0.44, 1.57) | ||||||||
Landers 2010 | United States | Mean ± SD: 33.7 ± 8.7 | F: 100% | General population | Use without prescription | 4.5 | 31 | 11 | 1.00 | Age, gender | |
13.0 | 42 | 18 | 1.36 (0.52, 3.55) | ||||||||
Sawalha 2010 | Palestine | – | NA | General population | Antibiotic Storage | 3.5 | 239 | 86 | 1.00 | – | |
10.0 | 591 | 162 | 0.67 (0.49, 0.93) | ||||||||
Togoobaatar 2010 | Mongolia | Mean ± SD: 35.4 ± 11.9 | F: 100% | General population | Use without prescription | 5.0 | 183 | – | 1.20 (0.70, 2.20) | Gender, occupation | |
12.0 | 320 | – | 1.00 | ||||||||
Abasaeed 2009 | United Arab Emirates | Adults ≤ 20 to > 50 | M: 65.8% F: 34.2% | Attendants of a book fair | Antibiotic storage | 3.5 | 163 | 37 | 1.00 | Age | |
11.0 | 191 | 48 | 1.14 (0.70, 1.87) | ||||||||
15.5 | 496 | 166 | 1.71 (1.14, 2.58) | ||||||||
Ilhan 2009 | Turkey | Adults (≥ 18) Mean ± SD: 39.5 ± 15.2 | M: 38.7% F: 61.3% | Attendants of primary care centers | Use without prescription | 4.0 | 906 | 141 | 1.00 | Age, gender, income, marital status, employment status, household size, healthcare insurance (social security), perceived health status, presence of chronic diseases | |
12.5 | 1787 | 373 | 1.43 (1.15, 1.78) | ||||||||
Sawair 2009 | Jordan | 16–65 | M: 46.1% F: 53.9% | Attendants of primary care centers | Use without prescription | 0.0 | 14 | 7 | 1.00 | Age, gender, income, marital status, employment status, healthcare insurance, smoking habits, self-reported health status, chronic comorbidities | |
5.5 | 37 | 15 | 0.68 (0.20, 2.35) | ||||||||
11.5 | 203 | 77 | 0.61 (0.21, 1.81) | ||||||||
15.5 | 198 | 85 | 0.75 (0.25, 2.23) | ||||||||
21.0 | 25 | 10 | 0.67 (0.18, 2.49) | ||||||||
Hadi 2008 | Indonesia | Adults (≥ 18) | M: 37.4% F: 62.6% | Attendants of primary care centers | Use without prescription | 2.5 | 63 | 26 | 1.00 | Age, gender, income, residential location, ethnicity, household size, healthcare insurance | |
6.0 | 402 | 192 | 1.30 (0.76, 2.22) | ||||||||
Mistretta 2008 | Italy | ≥ 10 Mean ± SD: 53.7 ± 17.7 | M: 41.3% F: 58.7% | Attendants of primary care centers | Use without prescription | 2.5 | 144 | 124 | 1.00 | Age, gender, occupation, family size | |
7.0 | 165 | 142 | 0.73 (0.36, 1.46) | ||||||||
11.0 | 195 | 160 | 0.62 (0.30, 1.28) | ||||||||
16.0 | 132 | 86 | 1.37 (0.65, 2.86) | ||||||||
Al-Azzam 2007 | Jordan | Unrestricted age category > 17 to < 60 | M: 48.8% F: 51.2% | General population | Use without prescription | 0.0 | 315 | 86 | 1.00 | – | |
5.5 | 396 | 143 | 1.51 (1.09, 2.08) | ||||||||
11.5 | 709 | 313 | 2.10 (1.58, 2.81) | ||||||||
15.5 | 713 | 300 | 1.93 (1.45, 2.58) | ||||||||
Grigoryan 2006 | 19 European countries | Adults (≥ 18) | M: 46.8% F: 53.2% | General population | Use without prescription | 6.0 | – | – | 1.00 | Age, gender, country, chronic diseases | |
14.0 | – | – | 1.36 (1.10, 1.68) | ||||||||
Antibiotic storage | 6.0 | – | – | 1.00 | |||||||
14.0 | – | – | 1.69 (1.47, 1.94) | ||||||||
Awad 2005 | Sudan | ≤ 20 to > 60 | M: 45.1% F: 54.9% | General population | Use without prescription | 0.0 | 156 | 63 | 1.00 | Age, gender, income | |
3.5 | 285 | 155 | 1.76 (1.18, 2.61) | ||||||||
7.5 | 392 | 262 | 2.98 (2.03, 4.36) | ||||||||
10.0 | 474 | 413 | 9.99 (6.58, 15.18) | ||||||||
14.5 | 443 | 400 | 13.73 (8.77, 21.51) | ||||||||
Parimi 2002 | Trinidad and Tobago | Adults (≥ 18) | M: 33.3% F: 66.7% | General population | Use without prescription | 3.5 | 126 | 34 | 1.00 | Age | |
9.5 | 323 | 71 | 0.76 (0.47, 1.22) | ||||||||
14.5 | 147 | 25 | 0.55 (0.31, 0.99) | ||||||||
Antibiotic storage | 3.5 | 124 | 26 | 1.00 | |||||||
9.5 | 308 | 74 | 1.19 (0.72, 1.98) | ||||||||
14.5 | 147 | 28 | 0.89 (0.49, 1.61) | ||||||||
Bi 2000 | China | – | F: 100% | Children caregivers | Use without prescription | 3.5 | 140 | 65 | 1.00 | Gender | |
8.0 | 442 | 259 | 1.63 (1.11, 2.39) | ||||||||
11.0 | 780 | 478 | 1.83 (1.27, 2.62) | ||||||||
14.5 | 97 | 65 | 2.34 (1.37, 4.01) | ||||||||
Saradamma 2000 | India | > 6 | M: 48.5% F: 51.5% | General population | Use without prescription | 4.0 | 87 | 38 | 1.00 | – | |
10.5 | 136 | 24 | 0.28 (0.15, 0.51) | ||||||||
14.5 | 137 | 8 | 0.08 (0.04, 0.18) | ||||||||
19.0 | 45 | 3 | 0.09 (0.03, 0.32) |